Imatinib Compared with Chemotherapy as Front-Line Treatment of Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

WU De-pei; ZHONG Li-ye

doi:10.3969/j.issn.1671-5144.2009.05.011

WU De-pei, ZHONG Li-ye. Imatinib Compared with Chemotherapy as Front-Line Treatment of Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 270-273. DOI: 10.3969/j.issn.1671-5144.2009.05.011

Citation:

WU De-pei, ZHONG Li-ye. Imatinib Compared with Chemotherapy as Front-Line Treatment of Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 270-273. DOI: 10.3969/j.issn.1671-5144.2009.05.011

Citation:

WU De-pei, ZHONG Li-ye. Imatinib Compared with Chemotherapy as Front-Line Treatment of Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 270-273. DOI: 10.3969/j.issn.1671-5144.2009.05.011

Imatinib Compared with Chemotherapy as Front-Line Treatment of Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Imatinib Compared with Chemotherapy as Front-Line Treatment of Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Graphical Abstract

Catalog

Export File

Citation

Format

Content